Companies /Healthcare

Oscar Health Inc - Class A

NYSE: OSCR Healthcare Plans
$32.04
▲ $0.06 (+0.19%) today
Markets open · 10:11am ET

Q1 2025 Earnings

Reported May 7, 2025, 6:24am ET · SEC source
$0.92
Beat +13.93%
EPS · est. $0.81
$3.0B
Beat +6.31%
Revenue · est. $2.9B
−20.2%
Trailing market
OSCR vs S&P since report
2 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−10%0+10%+20%May 7May 8report 6:24am ETearnings+1.2%+14.7%
−10%0+10%+20%May 7May 8earnings+1.2%+14.7%
OSCR +14.7%S&P 500 +1.2%
−10%0+10%+20%May 7May 8report 6:24am ETearnings+1.5%+14.7%
−10%0+10%+20%May 7May 8earnings+1.5%+14.7%
OSCR +14.7%NASDAQ +1.5%
0+20%May 6May 15report 6:24am ETearnings+4.1%+5.5%
0+20%May 6May 15earnings+4.1%+5.5%
OSCR +5.5%S&P 500 +4.1%
0+20%May 6May 15report 6:24am ETearnings+6.5%+5.5%
0+20%May 6May 15earnings+6.5%+5.5%
OSCR +5.5%NASDAQ +6.5%
+30.22%
Day of report
+0.24%
Next session
−2.82%
One week
−13.28%
30 days

S&P 500 over the same 30 days: +6.87%.

Did OSCR Beat Earnings? Q1 2025 Results

Oscar Health kicked off 2025 with a standout first quarter, posting earnings per share of $0.92 against a consensus estimate of $0.81, a beat of nearly 14%, while revenue of $3.05 billion cleared expectations by 6.31% and surged 42.2% year over year. The primary engine behind that revenue acceleration was membership growth, with total effectuated members climbing to roughly 2.04 million from 1.45 million a year earlier, translating premium revenue to $3.00 billion from $2.09 billion in Q1 2024. That scale delivered meaningful operating leverage, driving the SG&A expense ratio down to 15.8% from 18.4%, even as the medical loss ratio edged higher to 75.4% partly due to $31.00 million of unfavorable prior period risk adjustment development. Net income attributable to Oscar reached $275.27 million, with adjusted EBITDA rising to $328.83 million. The company, which has centered its ACA marketplace strategy on tech-powered plan design and specialized chronic condition offerings, reaffirmed its full year 2025 outlook, continuing to guide for meaningful margin expansion ahead.

Key Takeaways
  • Higher membership driving 42% year-over-year revenue growth
  • Fixed cost leverage reducing SG&A expense ratio to 15.8% from 18.4%
  • Variable cost efficiencies and lower exchange fee rates
  • Total effectuated members grew to approximately 2.04 million from 1.45 million year-over-year
  • Individual and Small Group members grew to 2,021,484 from 1,386,980

“Oscar reported strong financial results in the first quarter. We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners.”

Oscar Health CEO, on the earnings call

Forward Guidance & Outlook

Oscar Health reaffirmed its full year 2025 outlook across all metrics as originally provided in its financial results press release dated February 4, 2025. The company continues to expect meaningful margin expansion in 2025 as it delivers superior value to members and partners.

OSCR YoY Financials

Q1 2025 vs Q1 2024 · SEC filings Q1 2024 Q1 2025
$0$900.0M$1.8B$2.7B$2.1B$3.0BRevenue$178.5M$297.1MOperating Income$177.4M$275.5MNet Income
$0$900.0M$1.8B$2.7BRevenueOperating IncomeNet Income

OSCR Revenue by Segment

Individual & Small Group

Figures from SEC filings and company reports. Not investment advice.